TTM
13.9%
YoY change
−3.69pp
Trough year (2003)
-470.1%
Peak year (2019)
41.0%
Latest annual
13.2%
Net Profit Margin history chart for Biogen (BIIB) from 1985 to 2025
Latest: 13.2%
Net Profit Margin change chart for Biogen (BIIB) from 1985 to 2025
Latest: −3.69pp
Net Profit Margin history table for Biogen (BIIB) from 1985 to 2025
| 2025 | 13.2% | -3.69pp | ||
| 2024 | 16.9% | +5.06pp | ||
| 2023 | 11.8% | -18.14pp | ||
| 2022 | 29.9% | +15.78pp | ||
| 2021 | 14.2% | -15.59pp | ||
| 2020 | 29.8% | -11.20pp | ||
| 2019 | 41.0% | +8.02pp | ||
| 2018 | 32.9% | +12.25pp | ||
| 2017 | 20.7% | -11.66pp | ||
| 2016 | 32.3% | -0.61pp | ||
| 2015 | 33.0% | +2.71pp | ||
| 2014 | 30.2% | +3.38pp | ||
| 2013 | 26.9% | +1.84pp | ||
| 2012 | 25.0% | +0.57pp | ||
| 2011 | 24.5% | +3.14pp | ||
| 2010 | 21.3% | -0.85pp | ||
| 2009 | 22.2% | +3.05pp | ||
| 2008 | 19.1% | -1.01pp | ||
| 2007 | 20.1% | +12.01pp | ||
| 2006 | 8.1% | -1.27pp | ||
| 2005 | 9.4% | +7.81pp | ||
| 2004 | 1.6% | +471.72pp | ||
| 2003 | -470.1% | -506.78pp | ||
| 2002 | 36.6% | +10.47pp | ||
| 2001 | 26.2% | -9.88pp | ||
| 2000 | 36.0% | +8.29pp | ||
| 1999 | 27.7% | +2.87pp | ||
| 1998 | 24.9% | +4.33pp | ||
| 1997 | 20.5% | +5.92pp | ||
| 1996 | 14.6% | +10.90pp | ||
| 1995 | 3.7% | +6.86pp | ||
| 1994 | -3.1% | -26.89pp | ||
| 1993 | 23.8% | -7.21pp | ||
| 1992 | 31.0% | +19.24pp | ||
| 1991 | 11.7% | -3.64pp | ||
| 1990 | 15.4% | +4.14pp | ||
| 1989 | 11.2% | +17.05pp | ||
| 1988 | -5.8% | +256.97pp | ||
| 1987 | -262.8% | +177.83pp | ||
| 1986 | -440.6% | -314.13pp | ||
| 1985 | -126.5% | — |
- 202513.2%-3.69pp
- 202416.9%+5.06pp
- 202311.8%-18.14pp
- 202229.9%+15.78pp
- 202114.2%-15.59pp
- 202029.8%-11.20pp
- 201941.0%+8.02pp
- 201832.9%+12.25pp
- 201720.7%-11.66pp
- 201632.3%-0.61pp
- 201533.0%+2.71pp
- 201430.2%+3.38pp
- 201326.9%+1.84pp
- 201225.0%+0.57pp
- 201124.5%+3.14pp
- 201021.3%-0.85pp
- 200922.2%+3.05pp
- 200819.1%-1.01pp
- 200720.1%+12.01pp
- 20068.1%-1.27pp
- 20059.4%+7.81pp
- 20041.6%+471.72pp
- 2003-470.1%-506.78pp
- 200236.6%+10.47pp
- 200126.2%-9.88pp
- 200036.0%+8.29pp
- 199927.7%+2.87pp
- 199824.9%+4.33pp
- 199720.5%+5.92pp
- 199614.6%+10.90pp
- 19953.7%+6.86pp
- 1994-3.1%-26.89pp
- 199323.8%-7.21pp
- 199231.0%+19.24pp
- 199111.7%-3.64pp
- 199015.4%+4.14pp
- 198911.2%+17.05pp
- 1988-5.8%+256.97pp
- 1987-262.8%+177.83pp
- 1986-440.6%-314.13pp
- 1985-126.5%—
Net Profit Margin values are taken from Biogen's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Net Profit Margin at Biogen (BIIB)
According to Biogen's latest reported financial statements, the company's latest reported net margin is 13.9%. Net profit margin is net income divided by revenue — the bottom-line share of each sales dollar that remains after all costs, including operating expenses, interest, and taxes. It is the most comprehensive profitability ratio, though it can swing on one-off items, so read it alongside the multi-year trend below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Biogen (BIIB) net margin is 13.18% – contracted 3.7 percentage points year-over-year.
The record annual net margin stands at 40.96%, reached in 2019; the historical low of -470.14% was recorded in 2003.
Biogen Net Profit Margin by Year
Biogen Net Profit Margin 2025: 13.2%
2025's net margin for Biogen came in at 13.18%, contracted 3.7 percentage points from 2024.
Biogen Net Profit Margin 2024: 16.9%
Biogen posted net margin of 16.87% in 2024, expanded 5.1 percentage points from 2023.
Biogen Net Profit Margin 2023: 11.8%
In 2023, Biogen reported net margin of 11.81%, contracted 18.1 percentage points from 2022.
Biogen Net Profit Margin 2022: 29.9%
Biogen net margin in 2022 was 29.95%, expanded 15.8 percentage points from 2021.
Biogen Net Profit Margin 2021: 14.2%
Biogen net margin in 2021 was 14.17%.
See more financial history for Biogen (BIIB).
Sector peers by Net Profit Margin
Healthcare peers of Biogen (BIIB), ranked by their latest net margin
| 37.2% | |
| 35.0% | |
| 21.4% | |
| 20.9% | |
| 17.2% | |
| 13.6% | |
| 5.8% | |
| 2.7% |
- 37.2%
- 35.0%
- 20.9%
- 17.2%
- 13.6%
- 5.8%
Frequently asked questions
Biogen (BIIB) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation